Comparative analysis of metabolic characteristics and prognostic stratification of HER2-low and HER2-zero breast cancer using 18F-FDG PET/CT imaging
2024

Metabolic Characteristics of HER2-Low and HER2-Zero Breast Cancer

Sample size: 258 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gao Yuan, Yin Lei, Ma Linlin, Wu Caixia, Zhu Xiaojuan, Liu Hongjin, Liang Li, Chen Jinzhi, Chen Yulong, Ye Jingming, Xu Ling

Primary Institution: Peking University First Hospital

Hypothesis

This study aimed to comparatively analyze the metabolic characteristics and prognostic stratification of HER2-low and HER2-zero breast cancer using 18F-FDG PET/CT imaging.

Conclusion

The HR-positive HER2-low breast cancer exhibited a unique glucose metabolic profile, and HER2-zero patients with elevated metabolism had a poorer prognosis.

Supporting Evidence

  • SUVmax and TLR were significantly higher in HER2-low than in HER2-zero in the HR-positive subgroup.
  • The four metabolic parameters were significant predictors of disease-free survival in HER2-negative patients.
  • Higher metabolism in HER2-zero patients was associated with a shorter disease-free survival.

Takeaway

This study looked at how different types of breast cancer, specifically HER2-low and HER2-zero, use sugar for energy, which can help doctors understand how to treat these cancers better.

Methodology

The study reviewed consecutive patients with newly diagnosed breast cancer who underwent 18F-FDG PET/CT prior to therapy, analyzing metabolic parameters and survival outcomes.

Potential Biases

Retrospective case collation may be prone to inadvertent bias.

Limitations

The sample size was insufficient for thorough analysis, and the retrospective nature may introduce bias.

Participant Demographics

The study included 256 women (99.2%) and 2 men (0.8%), with a mean age of 54 ± 12 years.

Statistical Information

P-Value

P < 0.01 for metabolic parameters predicting DFS.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s40644-024-00812-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication